GranBio
GranBio is a biotechnology company that converts non-food cellulosic biomass into low-carbon biofuels, biochemicals, and Sustainable Aviation Fuel using proprietary AVAP® and GreenPower+® technologies, serving aviation, industrial, and consumer goods markets through commercial plants in the US and Brazil.
- Company typePrivate
- Founded2011
- HeadquartersBrasil, Brazil
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What GranBio does
GranBio is a biotechnology company founded in 2011 in Brazil, now operating from Atlanta, Georgia with manufacturing facilities in both the United States (Thomaston Biorefinery, Georgia) and Brazil (Bioflex plant, Alagoas). The company specializes in converting non-food cellulosic biomass — primarily wood and agricultural residues — into low-carbon biofuels, biochemicals, and Sustainable Aviation Fuel (SAF) using two proprietary technology platforms, AVAP® and GreenPower+®. These technologies have been in commercial use for over a decade with 10,000+ hours of validated runtime and independent third-party validation by ICF International. GranBio employs a brownfield expansion model, repurposing decommissioned assets such as shuttered Pulp & Paper mills to reduce CAPEX and accelerate time-to-market.
GranBio's product portfolio centers on cellulosic SAF, second-generation ethanol (anchored by the announced Exygen I project targeting 40 million gallons per year), and biochemicals serving transportation, pharmaceutical, food & beverage, and industrial customers. The company has publicly disclosed Amazon as a strategic partner supporting its SAF expansion from waste biomass, and the Bioflex plant in Brazil has obtained RSB Global Fuels certification from the Roundtable on Sustainable Biomaterials, enabling access to sustainability-premium markets. GranBio's stated ambition is to scale to 1 billion gallons per year of cellulosic SAF capacity by 2040 through repurposing ten Pulp & Paper mill plants across the United States.
The company generates revenue through direct enterprise sales of cellulosic biofuels and biochemicals to airlines, corporate aviation operators, fuel distributors, and industrial buyers, with pricing negotiated privately under long-term offtake agreements. GranBio employs an enterprise field sales go-to-market motion focused on large-scale SAF offtake and B2B engagement with fuel distributors and corporate partners. The company is privately held, led by Founder, President, and CEO Bernardo Gradin, with a workforce of 101–250 employees across its two-country footprint.
GranBio firmographics
Firmographics- Name
- GranBio
- Legal name
- GranBio
- Website
- https://granbio.com.br
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- GranBio is a biotechnology company that converts non-food cellulosic biomass into low-carbon biofuels, biochemicals, and Sustainable Aviation Fuel using proprietary AVAP® and GreenPower+® technologies, serving aviation, industrial, and consumer goods markets through commercial plants in the US and Brazil.
- Ownership category
- akta.pro rank
GranBio industry classification
Industry- Product category
- Advanced Biofuels / Sustainable Aviation Fuel
- NAICS
- Cyclic Crude, Intermediate, and Gum and Wood Chemical Manufacturing (325194), Biomass Electric Power Generation (221117)
- akta.pro primary industry
- Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates) (IMAMALAA)
- akta.pro secondary industries
- Biofuels & Renewable Fuels Switching (Biomethane/RNG, Bio-oils, Sustainable Biomass) (EUABAJAD), Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA)
Keywords
Where GranBio is headquartered
LocationHeadquarters
- HQ city
- Brasil
- HQ country
- Brazil
- HQ region
- Latin America
Offices3 records
Markets served
GranBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Infrastructure, Personnel
Revenue model
- Sustainable Aviation Fuel (SAF) Sales: Production and sale of cellulosic-based Sustainable Aviation Fuel to airlines and corporate aviation customers, generating revenue through volume-based fuel sales agreements.
- Biofuels and Biochemicals Sales: Sale of low-carbon biofuels and biochemicals derived from cellulosic biomass for transportation, pharma, food & beverage, and industrial applications.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
GranBio product offering
Product offeringCore offering
GranBio converts cellulosic, non-food biomass (wood and agricultural residues) into low-carbon biofuels and biochemicals using its proprietary AVAP® and GreenPower+® conversion technologies. Its commercial products include Sustainable Aviation Fuel (SAF), second-generation cellulosic ethanol, and biochemicals for transportation, pharmaceutical, food & beverage, and industrial applications, produced at biorefineries in Georgia, U.S. and Alagoas, Brazil.
Product overview
GranBio offers a portfolio of cellulosic bioproducts centered on three core offerings: Sustainable Aviation Fuel (SAF), cellulosic ethanol (Exygen I project), and biochemicals. These products are produced using two proprietary technology platforms—AVAP® and GreenPower+®—which have been extensively validated with over 10,000 hours of runtime across GranBio's biorefineries in Georgia, US and Alagoas, Brazil. The company operates on a brownfield model, repurposing decommissioned pulp and paper mills to achieve cost-competitive production, targeting 1 billion gallons per year of cellulosic SAF capacity by 2040 through ten repurposed facilities in the United States.
Differentiator
Problem solved
Functional benefit
Products and services
- Sustainable Aviation Fuel (SAF)
Quantifiable outcome
- 1 billion gallons per year SAF capacity target by 2040
- +2 more outcomes
Companies that use GranBio
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
GranBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
GranBio partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AmazoncoreAmazon is supporting GranBio's work to advance the production of sustainable aviation fuel (SAF) from waste biomass. This strategic partnership provides a major enterprise customer for GranBio's SAF production and helps Amazon meet its sustainability and decarbonization commitments for aviation operations.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
GranBio competitors and assessment
Company assessmentDirect peers
- Velocys: Velocys develops Fischer-Tropsch-based SAF and has commercial projects targeting airlines and fuel distributors, making it a direct technology and market competitor to GranBio's SAF production.
- Gevo: Gevo produces low-carbon SAF and renewable hydrocarbons from corn and cellulosic feedstocks using alcohol-to-jet technology, competing directly with GranBio's cellulosic SAF and targeting the same airline customers.
- Iogen: Iogen is a long-standing cellulosic ethanol technology developer with commercial deployments; its enzymatic biomass-to-ethanol platform competes head-to-head with GranBio's AVAP® and GreenPower+® technologies.
- Aemetis: Aemetis produces cellulosic and renewable SAF, renewable diesel, and ethanol at commercial scale in California, targeting similar airline offtakes and operating a comparable cellulosic-to-jet pathway.
- LanzaTech: LanzaTech produces cellulosic/carbon-gas-based ethanol that is upgraded to SAF and chemicals via partnerships (including with airlines and technology licensors). It is a direct competitor to GranBio's 2G ethanol→SAF pathway and pursues similar aviation offtake agreements.
Regional players
- Cosan: Cosan is the parent of Raízen and a Brazilian conglomerate with significant biofuels, sugar, and logistics assets, positioning it as a regional incumbent comparable to GranBio in the Brazilian bioeconomy.
- Raízen: Raízen is Brazil's largest sugar/ethanol producer and a major SAF producer in Brazil; it competes directly with GranBio in the Brazilian market for cellulosic ethanol, biochemicals, and SAF offtake.
Emerging players
- Sunfire: Sunfire produces e-SAF via power-to-liquid and is building commercial projects with airlines and fuel majors; it competes for SAF offtake customers but uses a different (electrolytic) feedstock pathway.
- Raven SR: Raven SR converts organic waste to renewable fuels including SAF using a non-combustion thermal process; it targets the same low-carbon aviation fuel market as GranBio from a waste-feedstock angle.
Broad incumbents
- POET: POET is the largest U.S. ethanol producer and is developing cellulosic and SAF capacity; as a broad incumbent it competes for feedstocks, policy support, and downstream SAF customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
GranBio social profiles
Digital presenceGranBio compliance and trust
Trust signalCompliance1 record
GranBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
GranBio leadership team
Management profileNumber of profiles
Profiles1 record
GranBio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GranBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GranBio
What does GranBio do?
GranBio converts cellulosic, non-food biomass (wood and agricultural residues) into low-carbon biofuels and biochemicals using its proprietary AVAP® and GreenPower+® conversion technologies. Its commercial products include Sustainable Aviation Fuel (SAF), second-generation cellulosic ethanol, and biochemicals for transportation, pharmaceutical, food & beverage, and industrial applications, produced at biorefineries in Georgia, U.S. and Alagoas, Brazil.
Is GranBio a public or private company?
GranBio is a private company. It is classified as unknown and is currently operating.
When was GranBio founded?
GranBio was founded in 2011. It employs 101 to 250 people.
Where is GranBio based?
GranBio is headquartered in Brasil, Brazil, in the Latin America region.
How does GranBio make money?
Two revenue lines are on record. Sustainable Aviation Fuel (SAF) Sales are the primary driver. The others are biofuels and Biochemicals Sales.
Who are GranBio's main competitors?
Direct peers on record are Velocys, Gevo, Iogen, Aemetis and LanzaTech. Regional players are Cosan and Raízen. Emerging players are Sunfire and Raven SR. POET is listed as a broad incumbent.
Does GranBio have an API?
No public API is recorded for GranBio.
What industry is GranBio in?
GranBio's product category is Advanced Biofuels / Sustainable Aviation Fuel. Its primary akta.pro industry code is IMAMALAA, Cellulosic Biofuels & Renewable Fuels (2G ethanol, SAF intermediates), with a secondary code of EUABAJAD, Biofuels & Renewable Fuels Switching (Biomethane/RNG, Bio-oils, Sustainable Biomass). Its NAICS code is 325194.